Abstract:This study explores the use of bacteria to mitigate ibuprofen (IBU) contamination in wastewater. Four new bacterial strains were identified that can grow with IBU as the only carbon source and demonstrated significant IBU removal efficiencies. In‐depth analysis revealed that two strains, Klebsiella pneumoniae TIBU2.1 and Mycolicibacterium aubagnense HPB1.1, possess genes encoding proteins similar to enzymes involved in IBU degradation, providing a promising avenue for bioremediation in IBU‐contaminated environments. Ibuprofen (IBU) is a significant contaminant frequently found in wastewater treatment plants due to its widespread use and limited removal during treatment processes. This leads to its discharge into the environment, causing considerable environmental concerns. The use of microorganisms has recently been recognized as a sustainable method for mitigating IBU contamination in wastewater. In this study, new bacteria capable of growing in a solid medium with IBU as the only carbon source and removing IBU from a liquid medium were isolated from environmental samples, including soil, marine, mine, and olive mill wastewater. Four bacterial strains, namely Klebsiella pneumoniae TIBU2.1, Klebsiella variicola LOIBU1.1, Pseudomonas aeruginosa LOIBU1.2, and Mycolicibacterium aubagnense HPB1.1, were identified through 16S rRNA gene sequencing. These strains demonstrated significant IBU removal efficiencies, ranging from 60 to 100% within 14 days, starting from an initial IBU concentration of 5 mg per litre. These bacteria have not been previously reported in the literature as IBU degraders, making this work a valuable contribution to further studies in the field of bioremediation in environments contaminated by IBU. Based on the IBU removal results, the most promising bacteria, K. pneumoniae TIBU2.1 and M. aubagnense HPB1.1, were selected for an in silico analysis to identify genes potentially involved in IBU biodegradation. Interestingly, in the tests with TIBU2.1, a peak of IBU transformation product(s) was detected by high‐performance liquid chromatography, while in the tests with HPB1.1, it was not detected. The emerging peak was analysed by liquid chromatography–mass spectrometry, indicating the presence of possible conjugates between intermediates of IBU biodegradation. The proteins encoded on their whole‐genome sequences were aligned with proteins involved in an IBU‐degrading pathway reported in bacteria with respective catabolic genes. The analysis indicated that strain HPB1.1 possesses genes encoding proteins similar to most enzymes reported associated with the IBU metabolic pathways used as reference bacteria, while strain TIBU2.1 has genes encoding proteins similar to enzymes involved in both the upper and the lower part of that pathway. Notably, in the tests with the strain having more candidate genes encoding IBU‐catabolic enzymes, no IBU transformation products were detected, while in the tests with the strain having fewer of these genes, detection occurred.

Biotransformation activities of fungal strain apiotrichum sp. IB-1 to ibuprofen and naproxen

Insights into the Substrate Tolerance of Enzymes Involved in the Nosiheptide Biosynthesis Pathway Based on Indolic Acid Moiety

Weak electrostimulation enhanced the microbial transformation of ibuprofen and naproxen

Identification of a Novel Ibuprofen Biotransformation Pathway in Streptomyces sp. D218 and Detoxification as Indicated by the Green Algae Scenedesmus obliquus

Production of 8-Prenylnaringenin from Isoxanthohumol Through Biotransformation by Fungi Cells.

Transformation of the drug ibuprofen by : Reversible glycosylation and generation of hydroxylated metabolites

New bacterial strains for ibuprofen biodegradation: Drug removal, transformation, and potential catabolic genes

Microbial Transformation of Pharmaceuticals Naproxen, Bisoprolol, and Diclofenac in Aerobic and Anaerobic Environments

Utilization of naproxen by Amycolatopsis sp. Poz 14 and detection of the enzymes involved in the degradation metabolic pathway

Biotransformation of Betulonic Acid by the Fungus Rhizopus arrhizus CGMCC 3.868 and Antineuroinflammatory Activity of the Biotransformation Products

Ibuprofen degradation by mixed bacterial consortia: Metabolic pathway and microbial community analysis

Biotransformation of 20(R)-Panaxadiol by the Fungus Rhizopus Chinensis.

Microbial Biotransformation of Gentiopicroside by the Endophytic Fungus Penicillium Crustosum 2T01Y01.

Dissemination of nonsteroidal anti-inflammatory drugs (NSAIDs) and metabolites from wastewater treatment plant to soils and agricultural crops via real-scale different agronomic practices

Construction of biocatalysts based on P450BM3 for the degradation of non-steroidal anti-inflammatory drugs

Unraveling the potential of a combined nitritation-anammox biomass towards the biodegradation of pharmaceutically active compounds

Biodegradation of Microtoxic Phenylpropanoids (Phenylpropanoic Acid and Ibuprofen) by Bacteria and the Relevance for Their Removal from Wastewater Treatment Plants

Genetic Characterization of the Ibuprofen-Degradative Pathway of Rhizorhabdus wittichii MPO218

Microbial Transformation of A Sulfonamide Antibiotic Under Various Background Nutrient Conditions

Microbial transformation of 2-amino-4-methyl-3-nitropyridine

Aerobic degradation of ibuprofen in batch and continuous reactors by an indigenous bacterial community